Notice: This company has been marked as potentially delisted and may not be actively trading. ZIOPHARM Oncology (ZIOP) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Best Global Universities for OncologySeptember 11, 2024 | usnews.comAlx Oncology Holdings (ALXO)February 10, 2024 | investing.comCG Oncology IncJanuary 31, 2024 | reuters.comWhy Is Alaunos Therapeutics (TCRT) Stock Up 37% Today?December 18, 2023 | markets.businessinsider.comWBSPH 2024 - OncologySeptember 15, 2023 | newsweek.comGauging Ziopharm's Chances for Positive Sarcoma Drug Trial ResultsAugust 29, 2023 | thestreet.comZiopharm’s palifosfamide fails in first-line STS…June 21, 2023 | investing.comALX Oncology Holdings Inc Ordinary SharesJune 15, 2023 | morningstar.comIntratumoral Cancer Therapies Global Market Report 2023June 9, 2023 | finance.yahoo.comNatural Killer Cell Therapy Market 2023-2029 New Research Report by Industryreport.coMay 11, 2023 | marketwatch.comGlobal Drugs for Non-small Cell Lung Cancer Market Size 2023 to 2026 Size and Share Survey ReportMarch 27, 2023 | marketwatch.comChronic Lymphocytic Leukemia Market 2023 Size and Forecast to 2030March 27, 2023 | marketwatch.comUSA Community Oncology Services Market Competitor Scenario - Market Positioning And Player-Based Strategies, By The Business Research CompanyFebruary 23, 2023 | finance.yahoo.comVerdi Oncology's Horizon Oncology Announces Agreement with Integra Connect to Bring Value-Based Care to Central IndianaFebruary 18, 2023 | finance.yahoo.comGlobal Gene Therapy in Oncology Market Size is Booming Across the Globe and Witness Huge Growth by Key Players to 2030 By VMReportsFebruary 18, 2023 | marketwatch.comiBio shares more than double in value after hours on new immuno-oncology target programFebruary 18, 2023 | seekingalpha.comCancer Care Market is booming in near Future 2023-2028January 24, 2023 | marketwatch.comNerviano Medical Sciences S.r.l.: Nerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Inhibitor AssetJanuary 13, 2023 | finanznachrichten.deNerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Inhibitor AssetJanuary 12, 2023 | yahoo.comZiopharm Subpar Cancer Therapies Can't Support Lofty Market ValuationJanuary 5, 2023 | thestreet.comCancer Care Market : Share, Industry Size, Opportunities, Analysis and Forecast to 2028 with Top Countries DataNovember 26, 2022 | marketwatch.comOncology Clinician-Scientist Jason Luke, MD Named physIQ Medical AdvisorNovember 12, 2022 | finance.yahoo.comGadeta Appoints Scientific Advisory Board and Provides Business UpdateOctober 20, 2022 | finance.yahoo.comGlobal Cancer Care Market Size and Scope 2022 Research Report by Consumption, Revenue, Regions, Gross Margin and Forecast to 2026September 27, 2022 | marketwatch.comCelyad Oncology SA: Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations TransactionSeptember 24, 2022 | finanznachrichten.deCandel Therapeutics Announces Two Executive Leadership AppointmentsSeptember 7, 2022 | finance.yahoo.comWhy This Fund Manager Is Short ZiopharmSeptember 2, 2022 | thestreet.comBiotech Stock Mailbag: Ziopharm, Oncolytics, SareptaAugust 25, 2022 | thestreet.comGlobal Allogeneic Cell Therapy Market Size-Forecasts to 2027August 22, 2022 | finance.yahoo.comZIOPHARM Oncology (NASDAQ: ZIOP)August 18, 2022 | fool.comNorth America oncology market value to cross USD 246 billion by 2028August 9, 2022 | sg.finance.yahoo.comTesticular Cancer Drugs Market is Booming Right Now, let's Understand Market Size, Share and Forecast till 2028August 3, 2022 | marketwatch.comGene Therapies for Cancer Treatment Market to Garner Considerable Growth at a higher % of CAGR During the Study Period 2022-2028July 15, 2022 | marketwatch.comTesticular Cancer Drugs Market Size 2022 Report by Industrial Growth, Share, Emerging Trends, Latest Development, Segmentations and Forecast to 2028July 15, 2022 | marketwatch.comCellChorus Announces Scientific Advisory BoardJune 1, 2022 | finance.yahoo.comWhat Makes Ziopharm (TCRT) a New Buy StockMay 4, 2022 | nasdaq.comJnana Therapeutics Announces Appointment of Doug Pagán, MBA, as Chief Financial Officer and Chief Operating OfficerApril 26, 2022 | finance.yahoo.comImmuno-oncology Cell Therapy Market worth $34.69 Billion by 2030 - Exclusive Report by InsightAce AnalyticMarch 3, 2022 | finance.yahoo.comZIOPHARM Oncology (NASDAQ:ZIOP) Research Coverage Started at StockNews.comStockNews.com started coverage on ZIOPHARM Oncology in a research note on Tuesday. They issued a "sell" rating on the stock.February 22, 2022 | marketbeat.comZIOPHARM changes name to Alaunos Therapeutics; shares up 5% premarketJanuary 26, 2022 | seekingalpha.comZiopharm Oncology Highlights Operational Progress & Rebrands to Alaunos TherapeuticsJanuary 26, 2022 | finance.yahoo.comIs ZIOPHARM Oncology (NASDAQ:ZIOP) Weighed On By Its Debt Load?January 21, 2022 | finance.yahoo.comWhy Ziopharm Oncology Shares Rose 10.5% on WednesdayJanuary 19, 2022 | finance.yahoo.comZacks Investment Research Downgrades ZIOPHARM Oncology (NASDAQ:ZIOP) to HoldZacks Investment Research lowered shares of ZIOPHARM Oncology from a "buy" rating to a "hold" rating in a research note on Tuesday.January 18, 2022 | marketbeat.comAs ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) drops to US$212m market cap, insiders might rethink their US$639k stock purchase earlier this yearJanuary 11, 2022 | nasdaq.comECMOHO Limited Announces the Appointment of independent director of the BoardDecember 6, 2021 | finance.yahoo.comZIOPHARM Oncology (ZIOP) Sees Hammer Chart Pattern: Time to Buy?November 23, 2021 | finance.yahoo.comBullish insiders at ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) loaded up on US$639k of stock earlier this yearNovember 22, 2021 | finance.yahoo.comIs ZIOPHARM Oncology (NASDAQ:ZIOP) Using Too Much Debt?November 11, 2021 | nasdaq.comZiopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual MeetingNovember 9, 2021 | finance.yahoo.com Get ZIOPHARM Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIOP and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! ZIOP Media Mentions By Week ZIOP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZIOP News Sentiment▼0.000.47▲Average Medical News Sentiment ZIOP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZIOP Articles This Week▼00▲ZIOP Articles Average Week Get ZIOPHARM Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIOP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FHTX News Today IRWD News Today EBS News Today RIGL News Today SGMO News Today CDXS News Today XOMA News Today VNDA News Today LXRX News Today VSTM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZIOP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIOPHARM Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIOPHARM Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
